4.6 Article

Changes of flavin-containing monooxygenases and trimethylamine-N-oxide may be involved in the promotion of non-alcoholic fatty liver disease by intestinal microbiota metabolite trimethylamine

Journal

Publisher

ACADEMIC PRESS INC ELSEVIER SCIENCE
DOI: 10.1016/j.bbrc.2022.01.060

Keywords

NAFLD; TMA; TMAO; FMOs; UPR

Funding

  1. National Natural Science Foundation of China [82100603]

Ask authors/readers for more resources

This study explored the role of trimethylamine (TMA) in nonalcoholic fatty liver disease (NAFLD) and found that TMA and its metabolite trimethylamine-N-oxide (TMAO) are closely related to NAFLD. The expression of flavin-containing monooxygenase 1 (FMO1) was increased in NAFLD, and FMO1 and its metabolite TMAO were induced by high fat and TMA. However, silencing FMO1 blocked the effects of high fat and TMA on TMAO. Furthermore, TMAO may exert its role in NAFLD through the activation of unfolded protein response (UPR).
Evidence shows that trimethylamine (TMA)/trimethylamine-N-oxide (TMAO) is closely related to nonalcoholic fatty liver disease (NAFLD). The conversion of TMA to TMAO is mainly catalyzed by flavincontaining monooxygenases 3 (FMO3) and FMO1. In this study, we explored the role of TMA in the process of NAFLD. The human NAFLD liver puncture data set GSE89632 and rat TMAO gene chip GSE135856 was downloaded for gene differential expression analysis. Besides, oleic acid (OA) combined with palmitate were used to establish high-fat cell model. TMA, TMAO and FMO1-siRNA were used to stimulate L02 cells. Contents of free fatty acid (FFA), triglyceride (TG), TMAO, FMO1 and unfolded protein response (UPR) related proteins GRP78, XBP1, Derlin-1 were detected. Our results showed that FMO1 and PEG10 were important in the progression of NAFLD. Immunohistochemistry showed that FMO1 in NAFLD liver was increased. In addition, the contents of FFA, TG, FMO1 expression, and TMAO were significantly increased after OA thorn palmitate and TMA stimulation. However, after silencing FMO1 with siRNA, the expressions of these molecules were decreased. Besides, the protein levels of GRP78, XBP1, Derlin-1 were increased after TMAO treatment (all P < 0.05). In Conclusion, high fat and TMA could induce the expression of FMO1 and its metabolite TMAO. When FMO1 is silenced, the effects of high fat and TMA on TMAO are blocked. And the role of TMAO in NAFLD may be through the activation of UPR. (c) 2022 Elsevier Inc. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available